Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hillier, S.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hillier, S.G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 9, No. 2, pp. 188-191, 1994
© 1994 European Society of Human Reproduction and Embryology


review-article

Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis

S.G. Hillier

Reproductive Endocrinology Laboratory, University of Edinburgh Centre for Reproductive Biology 37 Chalmers Street, Edinburgh EH3 9EW, UK

Around 400 follicles sequentially mature and ovulate during an average women‘s reproductive lifetime. From birth to the menopause, the other ~99.98% of her follicles begin development but never complete it. Instead they default to atresia due to inadequate stimulation by follicle stimulating hormone (FSH). Follicular growth to the stage of antrum formation (~0.25 mm diameter) is independent of gonadotrophic stimulation. Antrum formation and further growth to the stage at which follicles become potentially able to begin pre-ovulatory development (2–5 mm diameter) require tonic stimulation by FSH. Before onset of puberty, blood concentrations of FSH do not rise sufficiently to sustain development beyond this stage, therefore all antral follicles become atretic. After puberty, as each menstrual cycle begins, FSH concentrations rise beyond a critical ‘threshold’ and multiple follicles are recruited to begin pre-ovulatory development. Due to increases in its responsiveness to FSH and luteinizing hormone (LH), one of these follicles becomes selected to ovulate while the remainder become atretic. At mid-follicular phase, the dominant follicle reaches ≥10 mm in diameter and increasingly synthesizes oestradiol. Tonic stimulation by FSH and LH, underpinned by local paracrine signalling, maintains oestrogen secretion by the dominant follicle, which grows to ≥20 mm in diameter before it ovulates in response to the mid-cycle LH surge. The development-related response to LH shown by the pre-ovulatory follicle raises the possibility that exogenous LH might be used as an adjunct to therapy with exogenous FSH in clinical ovulation induction regimens where the aim is to induce monovulation.

Key words: follicle development/FSH/LH/ovulation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
S. G. Hillier
Paracrine support of ovarian stimulation
Mol. Hum. Reprod., December 1, 2009; 15(12): 843 - 850.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
B.C.J.M. Fauser, B.M.J.L. Mannaerts, P. Devroey, A. Leader, I. Boime, and D.T. Baird
Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency
Hum. Reprod. Update, May 1, 2009; 15(3): 309 - 321.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
M.F.G. Verberg, N.S. Macklon, G. Nargund, R. Frydman, P. Devroey, F.J. Broekmans, and B.C.J.M. Fauser
Mild ovarian stimulation for IVF
Hum. Reprod. Update, January 1, 2009; 15(1): 13 - 29.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Jayaprakasan, B.K. Campbell, J.F. Hopkisson, J.S. Clewes, I.R. Johnson, and N.J. Raine-Fenning
Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone
Hum. Reprod., November 1, 2008; 23(11): 2577 - 2583.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. Franks, J. Stark, and K. Hardy
Follicle dynamics and anovulation in polycystic ovary syndrome
Hum. Reprod. Update, May 22, 2008; (2008) dmn015v1.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. A. Murray, A. K.E. Swales, R. E. Smith, M. D. Molinek, S. G. Hillier, and N. Spears
Follicular growth and oocyte competence in the in vitro cultured mouse follicle: effects of gonadotrophins and steroids
Mol. Hum. Reprod., February 1, 2008; 14(2): 75 - 83.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Smitz, A.N. Andersen, P. Devroey, J.-C. Arce, and for the MERIT Group
Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients
Hum. Reprod., March 1, 2007; 22(3): 676 - 687.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. Wang, H. Newton, J. A. Spaliviero, C. M. Allan, B. Marshan, D. J. Handelsman, and P. J. Illingworth
Gonadotropin Control of Inhibin Secretion and the Relationship to Follicle Type and Number in the hpg Mouse
Biol Reprod, October 1, 2005; 73(4): 610 - 618.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.N. Hugues, J. Soussis, I. Calderon, J. Balasch, R.A. Anderson, A. Romeu, and on behalf of the Recombinant LH Study Group
Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study
Hum. Reprod., March 1, 2005; 20(3): 629 - 635.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. A.F. Huirne, A. C.D. van Loenen, R. Schats, J. McDonnell, P. G.A. Hompes, J. Schoemaker, R. Homburg, and C. B. Lambalk
Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy
Hum. Reprod., February 1, 2005; 20(2): 359 - 367.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Popovic, M. Djurovic, A. Cetkovic, D. Vojvodic, S. Pekic, S. Spremovic, M. Petakov, S. Damjanovic, N. Milic, C. Dieguez, et al.
Inhibin B: A Potential Marker of Gonadal Activity in Patients with Anorexia Nervosa during Weight Recovery
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1838 - 1843.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. Jonard and D. Dewailly
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest
Hum. Reprod. Update, March 1, 2004; 10(2): 107 - 117.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Y.-P. Ho, J.-L. Hwang, M.-J. Chen, H.-F. Guu, and E. S.-C. Ho
What is the LH ceiling level for follicular growth arrest in late follicular phase?
Hum. Reprod., February 1, 2004; 19(2): 463 - 464.
[Full Text] [PDF]


Home page
Hum ReprodHome page
E. Loumaye, P. Engrand, Z. Shoham, S.G. Hillier, and D.T. Baird
Clinical evidence for an LH ceiling?
Hum. Reprod., December 1, 2003; 18(12): 2719 - 2720.
[Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. R. Baerwald, G. P. Adams, and R. A. Pierson
Characterization of Ovarian Follicular Wave Dynamics in Women
Biol Reprod, September 1, 2003; 69(3): 1023 - 1031.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Loumaye, P. Engrand, Z. Shoham, S. G. Hillier, D. T. Baird, and on behalf of the Recombinant LH Study Group
Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation
Hum. Reprod., February 1, 2003; 18(2): 314 - 322.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. chen, Q. Qiu, P. N. Lohstroh, J. W. Overstreet, and B. L. Lasley
Hormonal Characteristics in the Early Luteal Phase of Conceptive and Nonconceptive Menstrual Cycles
Reproductive Sciences, January 1, 2003; 10(1): 27 - 31.
[Abstract] [PDF]


Home page
Hum ReprodHome page
P. Y.K. Yong, D. T. Baird, K.J. Thong, A. S. McNeilly, and R. A. Anderson
Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation
Hum. Reprod., January 1, 2003; 18(1): 35 - 44.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Tesarik and C. Mendoza
Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence
Hum. Reprod., December 1, 2002; 17(12): 3129 - 3137.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. P. Cheung, S. M. Pride, B. H. Yuen, and L. Sy
In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome
Hum. Reprod., October 1, 2002; 17(10): 2540 - 2547.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Meduri, N. Charnaux, M.-A. Driancourt, L. Combettes, P. Granet, B. Vannier, H. Loosfelt, and E. Milgrom
Follicle-Stimulating Hormone Receptors in Oocytes?
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2266 - 2276.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Burgues
The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain
Hum. Reprod., December 1, 2001; 16(12): 2525 - 2532.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Greisen, T. Ledet, and P. Ovesen
Effects of androstenedione, insulin and luteinizing hormone on steroidogenesis in human granulosa luteal cells
Hum. Reprod., October 1, 2001; 16(10): 2061 - 2065.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Balasch, E. Vidal, J. Penarrubia, R. Casamitjana, F. Carmona, M. Creus, F. Fabregues, and J. A. Vanrell
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH
Hum. Reprod., August 1, 2001; 16(8): 1636 - 1643.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Filicori and G. E. Cognigni
Roles and Novel Regimens of Luteinizing Hormone and Follicle-Stimulating Hormone in Ovulation Induction
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1437 - 1441.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
J. Balasch, F. Fabregues, M. Creus, B. Puerto, J. Penarrubia, and J. A. Vanrell
Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens
Hum. Reprod., April 1, 2001; 16(4): 652 - 656.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. P. N. Themmen and I. T. Huhtaniemi
Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function
Endocr. Rev., October 1, 2000; 21(5): 551 - 583.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
E. A. McGee and A. J. W. Hsueh
Initial and Cyclic Recruitment of Ovarian Follicles
Endocr. Rev., April 1, 2000; 21(2): 200 - 214.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
P. Touraine, I. Beau, A. Gougeon, G. Meduri, A. Desroches, C. Pichard, M. Detoeuf, B. Paniel, M. Prieur, J-R Zorn, et al.
New Natural Inactivating Mutations of the Follicle-Stimulating Hormone Receptor: Correlations between Receptor Function and Phenotype
Mol. Endocrinol., November 1, 1999; 13(11): 1844 - 1854.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Filicori, G. E. Cognigni, S. Taraborrelli, D. Spettoli, W. Ciampaglia, C. Tabarelli de Fatis, and P. Pocognoli
Luteinizing Hormone Activity Supplementation Enhances Follicle-Stimulating Hormone Efficacy and Improves Ovulation Induction Outcome
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2659 - 2663.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
J. F. Couse and K. S. Korach
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Endocr. Rev., June 1, 1999; 20(3): 358 - 417.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. S. Willis, H. Watson, H. D. Mason, R. Galea, M. Brincat, and S. Franks
Premature Response to Luteinizing Hormone of Granulosa Cells from Anovulatory Women with Polycystic Ovary Syndrome: Relevance to Mechanism of Anovulation
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3984 - 3991.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. E. R. H. L. S. Group
Recombinant Human Luteinizing Hormone (LH) to Support Recombinant Human Follicle-Stimulating Hormone (FSH)-Induced Follicular Development in LH- and FSH-Deficient Anovulatory Women: A Dose-Finding Study
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1507 - 1514.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. Pantel, P. Robert, F. Troalen, M. Kujas, D. Bellet, and J.-M. Bidart
Characterization of Human Lutropin Carboxyl- Terminus Isoforms
Endocrinology, February 1, 1998; 139(2): 527 - 533.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.